Second-generation cobas ampliprep/cobas taqman HCV quantitative test for viral load monitoring: A novel dual-probe assay design

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 571-577

  Zitzer, Heike ^a   Heilek, Gabrielle ^b   Truchon, Karine ^a   Susser, Simone ^d   Vermehren, Johannes ^d   Sizmann, Dorothea ^c   Cobb, Bryan ^b   Sarrazin, Christoph ^d  

^a Roche Diagnostics Ltd   (Switzerland)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EQUIPMENT DESIGN; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PROBE; SENSITIVITY AND SPECIFICITY; SERUM; VIRUS IDENTIFICATION; VIRUS LOAD;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; NUCLEIC ACID PROBES; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84873047372     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01784-12     Document Type: Article

References (30)

1. European Association for the Study of the Liver. 2011. EASL clinical practice guidelines: management of hepatitis C virus infection. J. Hepatol. 55:245-264.
2. Ghany MG, Strader DB, Thomas DL, Seeff LB. 2009. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335- 1374.
3. Poordad F, Rajender KR, Martin P. 2008. Rapid virologic response: a new milestone in the management of chronic hepatitis C. Clin. Infect. Dis. 46:78-84.
4. de Leuw P, Sarrazin C, Zeuzem S. 2011. How to use virological tools for the optimal management of chronic hepatitis C. Liver Int. 31(Suppl 1):3-12.
5. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R. 2011. Boceprevir for previously treated chronic HCV genotype 1 infection. N. Engl. J. Med. 364:1207-1217.
6. Cobb B, Vilchez RA. 2011. An update on treatment of hepatitis C virus genotype 1 and viral load assessments. Hepatology 55:979 -980.
7. Ghany MR, Nelson DR, Strader DB, Thomas DL, Seeff LB. 2011. An update on treatment of genotype 1 chronic hepatitis C virus infection: practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54:1433-1444.
8. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S, ADVANCE Study Team. 2011. Telaprevir for previously untreated chronic hepatitis C virus infection. N. Engl. J. Med. 364:2405-2416.
9. Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP, SPRINT-2 Investigators. 2011. Boceprevir for untreated chronic HCV genotype 1 infection. N. Engl. J. Med. 364:1195-1206.
10. Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P, Nevens F, Müllhaupt B, Pockros P, Terg R, Shouval D, van Hoek B, Weiland O, Van Heeswijk R, De Meyer S, Luo D, Boogaerts G, Polo R, Picchio G, Beumont M, REALIZE Study Team. 2011. Telaprevir for retreatment of HCV infection. N. Engl. J. Med. 364:2417-2428.
11. Harrington PR, Zeng W, Naeger LK. 2012. Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment. Hepatology 55:1048 -1057.
12. Gourlain K, Soulier A, Pellegrin B, Bouvier-Alias M, Hézode C, Darthuy F, Rémiré J, Pawlotsky JM, DITTP Group. 2005. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay. J. Clin. Microbiol. 43:1669 -1673.
13. Ross RS, Viazov S, Sarr S, Hoffmann S, Kramer A, Roggendorf M. 2002. Quantitation of hepatitis C virus RNA by third generation of branched DNA-based signal amplification assay. J. Virol. Methods 101:159 -168.
14. Chevaliez S. 2011. Virological tools to diagnose and monitor hepatitis C virus infection. Clin. Microbiol. Infect. 17:116 -121.
15. Chevaliez S, Bouvier-Alias M, Pawlotsky JM. 2009. Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification. J. Clin. Microbiol. 47:1726 -1732.
16. Sarrazin C, Dragan A, Gärtner BC, Forman MS, Traver S, Zeuzem S, Valsamakis A. 2008. Evaluation of an automated, highly sensitive, real- time PCR-based assay (COBAS AmpliPrep/COBAS TaqMan) for quantification of HCV RNA. J. Clin. Virol. 43:162-168.
17. Schutten M. 2008. Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays. Expert Rev. Mol. Diagn. 8:369 -377.
18. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. 2007. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46: 22-31.
19. Elkady A, Tanaka Y, Kurbanov F, Sugauchi F, Sugiyama M, Khan A, Ali EM, Mouhamed L, Abou el-fetouh S, AbdEl-Hameed AR, Mizokami M. 2010. Performance of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4. J. Med. Virol. 82:1878 -1888.
20. Germer JJ, Yao J. 2009. Quantitation of genotype 4 hepatitis C virus RNA by the COBAS AmpliPrep/COBAS TaqMan hepatitis C virus test. Hepatology 50:1679 -1680.
21. Clinical and Laboratory Standards Institute. 2008. Protocols for determination of limits of detection and limits of quantification; approved guideline. CLSI document EP17-A. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2008. Estimation of total analytical error for clinical laboratory methods; approved guideline, second edition. NCCLS document EP21-A. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Clinical and Laboratory Standards Institute. 2008. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline, second edition. NCCLS document EP6-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
24. Clinical and Laboratory Standards Institute. 2008. Evaluation of precision performance of quantitative measurement methods; approved guideline, second edition. NCCLS document CLSI EP5-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
25. Clinical and Laboratory Standards Institute. 2008. Interference testing in clinical chemistry; approved guideline, second edition. NCCLS document CLSI EP7-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
26. Clinical and Laboratory Standards Institute. 2008. Method comparison and bias estimation using patient samples; approved guideline. CLSI document EP9-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
27. Pawlotsky JM. 2010. More sensitive hepatitis C virus RNA detection: what for? J. Hepatol. 52:783-785.
28. Sarrazin C, Shiffman ML, Hadziyannis SJ, Lin A, Colucci G, Ishida H, Zeuzem S. 2010. Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy. J. Hepatol. 52:832- 838.
29. Vermehren J, Colucci G, Gohl P, Hamdi N, Abdelaziz AI, Karey U, Thamke D, Zitzer H, Zeuzem S, Sarrazin C. 2011. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity. J. Clin. Microbiol. 49:3309 -3315.
30. Vermehren J, Yu ML, Monto A, Yao JD, Anderson C, Bertuzis R, Schneider G, Sarrazin C. 2011. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. J. Clin. Virol. 52:133-137.